Axogen, Inc. (AXGN) is listed on NASDAQ in Medical Device Stocks. It is $51.46, -0.52%, with a $2.8B market cap. RSI is 67.0, near overbought. The latest reported quarter met estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 67.0 Near Overbought
Market Cap $2.8B
Volume 806.9K
Fundamentals — 10-Q Q2 2026
Revenue $131.2M
Net Income $-21.1M
EPS $-0.40
Gross Margin 73.8%
Operating Margin -3.8%
Net Margin -16.1%
Debt / Equity 0.0x
P/E Ratio -128.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Wendell Amy McBride | Director | Sell | 13,353 | $48.42 | $646,592 | 2026 Aug 11 |
| Began Marc A | EVP & General Counsel | Sell | 67,500 | $47.34 | $3.2M | 2026 Aug 10 |
| Weiler Kathy Johnson | Director | Sell | 14,150 | $45.30 | $640,967 | 2026 Aug 7 |
| Wendell Amy McBride | Director | Sell | 1,647 | $42.60 | $70,162 | 2026 May 8 |
| Johnson John | Director | Sell | 11,050 | $43.26 | $477,968 | 2026 May 7 |
| Weiler Kathy Johnson | Director | Sell | 16,344 | $44.09 | $720,623 | 2026 May 7 |
| Kemp Jens | Chief Marketing Officer | Sell | 4,000 | $43.44 | $173,761 | 2026 May 7 |
| Hartley Lindsey Marie | CFO | Sell | 1,051 | $43.67 | $45,897 | 2026 May 7 |
| Quackenbush Doris | Sales VP | Sell | 3,878 | $43.51 | $168,720 | 2026 May 7 |
| Devinney Erick Wayne | Chief Innovation Officer | Sell | 5,221 | $32.84 | $171,458 | 2026 Mar 16 |
| Weiler Kathy Johnson | Director | Sell | 46,653 | $29.55 | $1.4M | 2025 Dec 16 |
| Wendell Amy McBride | Director | Sell | 43,684 | $29.31 | $1.3M | 2025 Dec 16 |
| Hartley Lindsey Marie | CFO | Sell | 14,812 | $29.86 | $442,286 | 2025 Dec 15 |
| Began Marc A | EVP & General Counsel | Sell | 13,222 | $30.00 | $396,660 | 2025 Dec 11 |
| Dale Michael D | Chief Executive Officer | Sell | 25,000 | $30.00 | $750,000 | 2025 Dec 10 |
| Thomas Paul | Director | Sell | 21,399 | $29.61 | $633,624 | 2025 Dec 9 |
| Dale Michael D | Chief Executive Officer | Sell | 61,463 | $31.21 | $1.9M | 2025 Dec 9 |
| Johnson John | Director | Sell | 45,379 | $30.64 | $1.4M | 2025 Dec 9 |
| Tyndall Joseph A. | Director | Sell | 25,108 | $30.98 | $777,846 | 2025 Dec 9 |
| DeVinney Erick Wayne | Chief Innovation Officer | Sell | 19,517 | $31.21 | $609,126 | 2025 Dec 9 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $120.37 | 51.4 | $4.0B |
| | $175.24 | 52.2 | $4.4B |
| | $72.05 | 49.2 | -- |
Take AXGN further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put AXGN in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Axogen, Inc. next reports.
Set alerts on AXGN
Get notified when Axogen, Inc. hits your price targets or technical conditions are met.
Get Started Free